Industry landscapes
Get Pro
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE LONDON EDITION 2026

London’s
healthtech industry,
in focus.

The companies, capital and talent shaping healthtech in London. Find the leaders. Understand the segments. See where the activity is.

Explore in Radar Read the key signals
Snapshot: Funding in USD
Illustrated cover for Healthtech Industry Landscape of London
GB
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Healthtech illustration
Companies tracked 1,632Healthtech ecosystem in London Disclosed funding $5.89B339 companies · all recorded rounds Companies hiring 51With open roles at the snapshot Tracked open roles 972 employers posted in the preceding 30 days
MEET THE COMPANIES

Explore London’s healthtech leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Explore the full landscape
Healthtech company highlights in London, snapshot 31 August 2026
Company
Nuancedragon.nuance.com$785.59M—4,077—
Babylonbabylonhealth.com$735M—2,573—
Humahuma.com$384.93M—287—
Floflo.health$269M—425—
Automataautomata.tech$177.42M—40Financial figure available in RadarView in Radar
Numannuman.com$159.62M—17Financial figure available in RadarView in Radar
Elvieelvie.com$157.63M—102—
Healthilylivehealthily.com$139M—63—
LivaNovalivanova.com—11 roles68Financial figure available in RadarView in Radar
Amber Therapeuticsamber-tx.com—6 roles9—
Zavazavamed.com—5 roles198—
LYMA Lifelyma.life—4 roles26$39.9MFYFY2024 filing
Skin + Meskinandme.com—4 roles9—
DataCluedataclue.co.uk—3 roles——
Inflowgetinflow.io—3 roles4—
Sanius Healthsaniushealth.com—3 roles——
CoMindcomind.io——36—
Doktorabcdoktorabc.com————
Healioshealios.org.uk——128Financial figure available in RadarView in Radar
HeliosXheliosx.com——191—
Hormonahormona.io——2—
Koothkoothplc.com——362Financial figure available in RadarView in Radar
Liftedliftedcare.com——90—
NHS Choicesnhs.uk——7,997—
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only
THE KEY SIGNALS

Healthtech industry KPIs in London

A few useful ratios bring the size of this ecosystem into perspective.

31 August 2026
Hiring participation3.1%

51 of 1,632 tracked companies have open roles.

Funding participation23.8%

388 of 1,632 tracked companies have a recorded round.

Top 3 funding share32.4%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$1.15M

Midpoint of 782 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 32.4% of disclosed capital, while 76.2% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How London healthtech has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

London healthtech
$0$256.36M$512.73M$769.09M$1.03B2016: $307.22M20162017: $200.62M20172018: $243.54M20182019: $815.34M20192020: $413.41M20202021: $899.52M20212022: $594.82M20222023: $443.86M20232024: $556.74M20242025: $279.49M2025
View the numbers
Annual healthtech funding and company formation in London
YearFunding (USD)FoundedRaising
2016$307.22M10850
2017$200.62M10050
2018$243.54M13052
2019$815.34M14369
2020$413.41M17482
2021$899.52M123100
2022$594.82M9174
2023$443.86M10061
2024$556.74M6760
2025$279.49M3241
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Nuance13.3%
  • Babylon12.5%
  • Huma6.5%
  • Other companies67.6%

Funding by stage

925 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel528 57.1%
Series A–B206 22.3%
Series C+ / PE23 2.5%
Grants, debt & other168 18.2%

Recent recorded rounds

Latest recorded rounds · USD
8 rounds

Swipe or scroll horizontally to browse.

Seed04/2026
Calibre $3.3M

Backed by Amino Collective and Daybreak Ventures and others.

Series A03/2026
Jaaq $17M

Backed by Meridian Health Ventures and Fuel Ventures and others.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series C03/2021
Humahuma.com$147.96M

Backed by Leaps by Bayer and Samsung NEXT and others.

Series D06/2023
Humahuma.com$82.03M

Backed by AstraZeneca and HAT and others.

Series C04/2022
Proximieproximie.com$80.54M

Backed by Advent Life Sciences and British Patient Capital and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
GBP · millions · consolidated

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2024 · annual statements grouped by reported fiscal year; exact entity periods remain on preview rows · 13 reporting entities from 586 eligible matches.

Revenue in covered accounts£80.6m

Sum of reporting-entity revenue; not London market sales.

Net profit / loss£-11.8m

Combined result for the same cohort.

Aggregate net margin-14.6%

Combined net income ÷ combined revenue.

Median company revenue£0.8m

The middle covered reporting entity.

Profitable entities+46.2%

6 of 13 covered entities.

Top-five concentration+95.7%

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2024 · 13 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

13 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
LONDON · INDUSTRY COHORTS

How does healthtech compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the London companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Busiest websites

30 of the 1,632 companies on this page carry a measured traffic record (1.8%); these are the largest of those, by monthly visits. The median among them is 389,267 visits.

CompanyMonthly visitsAuthorityMobile
Floflo.health5,110,2176893.5%
DrDoctordrdoctor.co.uk3,391,1213794.6%
Doktorabcdoktorabc.com3,053,1244983.5%
MedExpressmedexpress.co.uk2,764,6625194.1%
Animaanimahealth.com1,554,2784395.7%
Voyjoinvoy.com1,329,4464191.3%
Skin + Meskinandme.com1,317,3574295.9%
Zavazavamed.com1,299,5356482.8%
Manualmanual.co857,1544589.2%
Numannuman.com825,8264490.8%

Visits and authority are third-party web estimates, not company-reported figures.

Most-installed apps

266 of these companies (16.3%) publish at least one Android app — 437 apps in all, carrying 317.1M installs between them.

AppInstallsRatingStore category
Flo Ovulation & Period TrackerFlo198.7M4.7Health & Fitness
Peak – Brain Games & TrainingPeak29.4M4.4Education
Pregnancy Tracker: ammaamma24.4M4.6Parenting
NHS AppNHS Choices22.6M3.4Medical
SnoreLab : Record Your SnoringSnoreLab7M4.4Health & Fitness
Smoke Free - quit smoking nowSmoke Free3.3M4.7Health & Fitness
PhysiApp®PhysiApp3.3M4.8Health & Fitness
NHS Couch to 5KNHS Choices3M4.9Health & Fitness
myGP® - Book GP appointmentsmyGP2.7M4.7Medical
Moshi Kids: Sleep, Relax, PlayMoshi2M4.6Education

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q1–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Disease Self Management148273.6MFlo Ovulation & Period Tracker 198.7M
Online Health Information1054.4MPregnancy Tracker: amma 24.4M
Healthcare Booking Platforms9232.7MNHS App 22.6M
Continued Learning1030.2MPeak – Brain Games & Training 29.4M
Fitness & Wellness Tech4614.5MSnoreLab : Record Your Snoring 7M
Healthcare It24711.4MPhysiApp® 3.3M
Mom & Baby Care43.7MMoshi Kids: Sleep, Relax, Play 2M
Pre-K Edtech33.7MMoshi Monsters Egg Hunt 1.1M

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2023Q2: 152023Q2: 102023Q22023Q3: 62023Q3: 42023Q32023Q4: 52023Q4: 72023Q42024Q1: 52024Q1: 72024Q12024Q2: 82024Q2: 62024Q22024Q3: 132024Q3: 72024Q32024Q4: 92024Q4: 182024Q42025Q1: 112025Q1: 152025Q12025Q2: 172025Q2: 132025Q22025Q3: 92025Q3: 422025Q32025Q4: 102025Q4: 382025Q42026Q1: 72026Q1: 672026Q1

Darker bars are new releases, lighter bars apps updated. 356 of 437 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The London healthtech market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech838
Consumer digital823
Enterprise software462
Saas257
Life sciences253
Healthtech saas223
Loneliness economy152
B2c e-commerce145
Mental healthtech122
At home diagnostics108
Femtech87
Iot in healthcare83

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

838companies
3.9%have hiring activity

33 companies hiring · $3.59B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Subscription1,186
E-commerce - product279
Commission on transaction178
Physical commerce168
Fee-for-service150
E-commerce - service139
Advertising109
Freemium6
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Funding roundshypervisionsurgical.com ↗

A university spinout which specialises in hyperspectral imaging to assist surgeons has clinched a £17m funding boost from investors including London-listed IP Group.

Funding roundsdigitalclipboard.com ↗

Symvan Capital’s investment in Digital Clipboard exemplifies its commitment to backing innovative AI-driven solutions that deliver tangible operational benefits and substantial returns.

Funding roundstechspert.com ↗

Manchester-based private equity investor Palatine has pumped £5m into fast-growing, UK-based primary research platform Techspert with funding from its Growth Credit Fund to “drive headcount growth and further develop its AI offering.”

Funding roundsautomata.tech ↗

Automata lands $45M in Series C funding for AI-ready lab automation

Funding roundsoviva.com ↗

Invested USD 100m for a 13 percent ownership stake in Oviva, a leading profitable European provider of digital care for weight-related and chronic illnesses.

Mergers & acquisitionskoothplc.com ↗

virtual provider Kooth purchased Kismet Health’s pediatric telehealth platform in November.

Funding roundsgutology.co.uk ↗

Former radio presenter Ollie Gallant has raised €2 million (£1.8 million) to expand international sales of Alcester-based Gutology and its gut-friendly Oral Biome+ toothpaste, following his own health challenges.

Funding roundsspryt.com ↗

The investment values Spryt at $12.5m, Neill Dunwoody, the company’s co-founder and chief operations officer (COO) told SiliconRepublic.com.

Funding roundsflo.health ↗

In 2024, the British cycle app provider Flo Health alone received 200â while the company received millions of US dollars from investors.

Funding roundsviraxbiolabs.com ↗

The gross proceeds from the private placement are expected to be $5 million , before deducting placement agent fees and other offering expenses.

Full recorded event mix

Top 10 categories among 161 recorded events in the 24-month window.

Funding rounds
65
Mergers & acquisitions
27
Leadership moves
20
Company announcements
13
Earnings
11
Capital infusions
6
New products
6
Regulatory
4
Buyback
2
Incorporation
2
3 activity cards

Swipe or scroll horizontally to browse.

Leadership moves

1 tracked people moves

LivaNova ↗
Donald (Don) Zurbay

Appointment Board of Directors

Product launches

Products, platforms and features in the recorded window

Dyad ↗
ALIS DX

Feature

32Co ↗
32Coach

Orthodontic AI education tool and clinical coach

32Co ↗
AI-Powered Proposals

Patient-friendly note generation tool

Naitive ↗
OsteoSight

AI-enabled opportunistic bone health assessment tool

Ask Evidently

AI chat interface embedded in EHR

Regulatory events

4 recorded events

Valirx ↗

approved for tradingLondon Stock Exchange

CoMind ↗

CoMind ↗

anticipated FDA clearance by 2027FDA

CoMind ↗

seeking approvalUS Food and Drug Administration

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
hims & hers→Zava ↗Completed2026-02-20Not stated in snapshot
Kooth→Kismet HealthCompleted2026-01-29Not stated in snapshot
reliance→Pando ↗Rumored2025-08-23Not stated in snapshot
vitalhub→Induction Healthcare ↗Completed2025-08-06Not stated in snapshot
Huma→alunaAnnounced2025-05-20Not stated in snapshot
Huma Therapeutics→eConsult ↗Completed2025-05-19Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

4 postings in the preceding 12 months. The full 9-posting snapshot covers 6 employers.

Expand panel +

Most advertised job titles

Functional Assessor Pip Clinical Auditor1
1 internship postings

0 tracked postings mention remote work.

Skills employers mention

Top skills across 9 tracked postings in the available jobs snapshot.

Healthcare
6
Project Management
5
Agency
3
Digital
3
Level 3 Care
1
Pharmaceutical
1
Digital Project Management
1
Level 2 Care
1
Icu Assessment
1
Evaluation
1
THE PEOPLE BUILDING THE FIELD

Founders and leaders

1,025 founders and chief executives across 716 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

266 profiles with education records.

Imperial College London
51
University of Cambridge
51
University of Oxford
47
University College London
35
King’s College London
22
University of Warwick
10
London School of Economics and Political Science
10
University of Bristol
9

Prior employers

43 profiles with prior-work records.

Goldman Sachs
11
McKinsey
10
Google
6
Morgan Stanley
6
Boston Consulting Group
4
Microsoft
3
Facebook
2
Salesforce
2

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

68,530 articles in the measured 12-month window.

Expand panel +
68,530articles in the measured year
17,568articles in 2026Q1
60.5%positive tone in the latest complete year

News volume trends

Healthtech coverage tagged London · articles per complete quarter

07,67915,35923,03830,7182021Q2: 12,6432021Q22021Q3: 15,8482021Q4: 12,6532022Q1: 14,1422022Q2: 13,5532022Q22022Q3: 14,4962022Q4: 14,3022023Q1: 14,3102023Q2: 15,2102023Q22023Q3: 13,1372023Q4: 14,0772024Q1: 16,8312024Q2: 15,8682024Q22024Q3: 16,2412024Q4: 15,8332025Q1: 26,7112025Q2: 16,9242025Q22025Q3: 19,8262025Q4: 14,5912026Q1: 17,5682026Q1
View quarterly article counts
QuarterArticles
2021Q212,643
2021Q315,848
2021Q412,653
2022Q114,142
2022Q213,553
2022Q314,496
2022Q414,302
2023Q114,310
2023Q215,210
2023Q313,137
2023Q414,077
2024Q116,831
2024Q215,868
2024Q316,241
2024Q415,833
2025Q126,711
2025Q216,924
2025Q319,826
2025Q414,591
2026Q117,568

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
23,007 positive · 499 neutral · 20,835 negative
2022
30,325 positive · 875 neutral · 25,190 negative
2023
32,846 positive · 785 neutral · 23,022 negative
2024
37,890 positive · 859 neutral · 25,904 negative
2025
47,159 positive · 1,163 neutral · 29,600 negative

Leading coverage topics

Healthtech coverage tagged London · ranked by full-period article count.

International And Transnational Geographic Entities300,630 articles in the full recorded period
108,091 recent · 81,381 prior
Geopolitical Disputes And Contested Areas300,629 articles in the full recorded period
108,089 recent · 81,378 prior
Administrative And Political Subdivisions300,586 articles in the full recorded period
108,068 recent · 81,373 prior
International Political Relations40,075 articles in the full recorded period
12,207 recent · 8,586 prior
Security And Defense Policies26,531 articles in the full recorded period
8,468 recent · 5,837 prior
Covid 19 Vaccine Development And Efficacy Trials19,787 articles in the full recorded period
1,013 recent · 513 prior
International Relations And Diplomacy18,988 articles in the full recorded period
5,291 recent · 4,342 prior
International Sports Competitions16,552 articles in the full recorded period
3,536 recent · 4,174 prior
Trade Policies And Agreements14,766 articles in the full recorded period
6,627 recent · 4,168 prior
Human Rights Advocacy Reports10,949 articles in the full recorded period
3,046 recent · 2,431 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

United Kingdom comparison coverage

KeywordRecentPriorChange
countries4,1921,862125%
tariff negotiations3,9662,33170%
stock performance2,3791,58950%
free trade deals2,1551,036108%
trade dispute mechanisms1,845776138%
bilateral trade1,759707149%
foreign policy analysis1,37990852%
multilateral diplomacy1,35275779%
national security strategy1,216511138%
exchange rates1,081278289%
free casino games261,120-98%
social casino261,117-98%
sweepstakes casino271,116-98%
simulated gambling apps291,115-97%
fun play casinos281,114-97%

Event and signal lenses

United Kingdom comparison coverage

All complete annual cohorts shown
Rising

Regulatory Risk

799,484 classified articles

territories, disputed islands, countries

25.4% critical · 15.9% positive
Rising

Funding Momentum

99,318 classified articles

inflation reports fx, currency intervention policies, trade deficits fx

43.2% critical · 42.3% positive
Rising

Growth

179,646 classified articles

gdp growth forex, stock performance, inflation reports fx

29.6% critical · 48.1% positive

Healthtech coverage tagged London. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Healthtech research is working on

53,214 papers in the recorded worldwide scope.

Expand panel +
53,214papers
53,214worldwide comparison pool
—India-affiliated papers

Research orientation

Promising
15,812
Problem-identifying
15,414
Descriptive
9,998
Breakthrough
6,783
Cautionary
3,403
Comparative
1,341
Critical
463

Contribution mix

Empirical
22,567
Methods-led
13,145
Reviews
10,811
Position pieces
6,308
Theoretical
383

Tone counts: 46,301 positive · 2,052 neutral · 4,861 negative.

Common problems researchers identify
15,877 papers · 29.8% of this field
  • Health care5,383 papers
  • Digital health5,157 papers
  • Health informatics3,104 papers
  • Public health2,260 papers
  • Health administration1,986 papers
  • Nursing research1,665 papers
  • Psychological intervention1,634 papers
  • Mental health1,156 papers

Landmark: Implementation strategies: recommendations for specifying and reporting

Cautions
3,403 papers · 6.4% of this field
  • Health care1,001 papers
  • Digital health984 papers
  • Psychological intervention545 papers
  • Health informatics522 papers
  • Mental health342 papers
  • Public health312 papers
  • Health administration310 papers
  • Nursing research229 papers

Landmark: Deep Learning for Health Informatics

Opportunities
22,595 papers · 42.5% of this field
  • Health care5,726 papers
  • Digital health5,168 papers
  • Health informatics2,677 papers
  • Psychological intervention2,251 papers
  • Wearable computer1,817 papers
  • Mental health1,669 papers
  • Public health1,409 papers
  • Intervention1,351 papers

Landmark: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science

Leading institutions

University of Toronto
24,168
VA Center for Clinical Management Research
23,746
McMaster University
23,248
VA Ann Arbor Healthcare System
21,768
University College London
21,651
Harvard University
21,597

Leading researchers

Laura J. Damschroder
27,157
Heather Colquhoun
15,523
David C. Aron
14,752
Susan Kirsh
14,676
Rosalind E. Keith
14,545
J Alexander
14,434
Kelly K. O’Brien
14,344
Danielle Levac
14,344

Highly cited breakthrough-labelled papers

  • Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science14,434 citations
  • A Novel Cloud-Based Framework for the Elderly Healthcare Services Using Digital Twin724 citations
  • BSN-Care: A Secure IoT-Based Modern Healthcare System Using Body Sensor Network690 citations
  • The SAIL databank: linking multiple health and social care datasets659 citations
  • Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation547 citations

Common problems researchers identify

42,040 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Health System ResilienceCommon problems researchers identify · 01

Health System Resilience

1,142 papers

19.0% of this theme group

Examines factors and methods for building resilient health care systems and administrations.

Health informatics (400) · Health administration (281) · Nursing research (250) · Public health (273)

Resilient Health Care: a systematic review of conceptualisations, study methods and factors that develop resilience

Health systems resilience in practice: a scoping review to identify strategies for building resilience

View research history
YearShare index
202223.2
202321.1
202427.6
202544.8
Complex Disease Drug DevelopmentCommon problems researchers identify · 02

Complex Disease Drug Development

1,137 papers

18.9% of this theme group

Discusses multi‑target strategies, repurposing, and challenges in discovering drugs for intricate diseases.

Drug discovery (321) · Drug (197) · Drug development (103) · Disease (155)

A perspective on multi‐target drug discovery and design for complex diseases

Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer

View research history
YearShare index
2022157.3
2023161.8
2024169.7
2025211.5
Digital Health IntegrationCommon problems researchers identify · 03

Digital Health Integration

953 papers

15.9% of this theme group

Analyzes how digital tools affect universal health coverage and patient engagement across vulnerable populations.

Digital health (627) · Health care (357) · Digital transformation (69) · eHealth (97)

Technology and Universal Health Coverage: Examining the role of digital health

Engagement With and Acceptability of Digital Media Platforms for Use in Improving Health Behaviors Among Vulnerable Families: Systematic Rev

View research history
YearShare index
2022538.7
2023553.0
2024540.4
2025843.9
Telehealth ImplementationCommon problems researchers identify · 04

Telehealth Implementation

881 papers

14.7% of this theme group

Reviews practical challenges, evaluation methods, and pandemic‑driven adoption of remote care services.

Telemedicine (604) · Telehealth (394) · Health care (334) · Telerehabilitation (53)

Opportunities and challenges for telehealth within, and beyond, a pandemic

Strategies for Evaluating Telehealth

View research history
YearShare index
2022542.2
2023554.7
2024541.1
2025844.0
Precision OncologyCommon problems researchers identify · 05

Precision Oncology

703 papers

11.7% of this theme group

Focuses on molecular diagnostics, biomarkers, and resistance issues in personalized cancer treatment.

Precision medicine (480) · Personalized medicine (238) · Disease (116) · Precision oncology (28)

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

Personalizing Oncology: Perspectives and Prospects

View research history
YearShare index
20221255.2
20231115.6
20241012.0
20251296.9
Medical Device RegulationCommon problems researchers identify · 06

Medical Device Regulation

655 papers

10.9% of this theme group

Explores risk analysis, energy sources, and regulatory frameworks for emerging medical equipment and wearables.

Medical device (221) · Wearable computer (50) · Medical equipment (27) · Risk analysis (34)

Energy sources and their development for application in medical devices

Medical Devices and Health — Creating a New Regulatory Framework for Moderate-Risk Devices

View research history
YearShare index
202240.4
202342.2
202443.7
202572.1
Pandemic‑Driven TelemedicineCommon problems researchers identify · 07

Pandemic‑Driven Telemedicine

529 papers

8.8% of this theme group

Measures COVID‑19 impacts on telemedicine usage and evaluates specialty‑specific remote care experiences.

Pandemic (394) · Coronavirus disease 2019 (274) · 2019-20 coronavirus outbreak (69) · Telemedicine (258)

Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study

Telemedicine Evaluations in Neuro-Ophthalmology During the COVID-19 Pandemic: Patient and Physician Surveys

View research history
YearShare index
2022655.3
2023440.6
2024327.7
2025212.1

Cautions

9,548 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Telemedicine Outcome ConcernsCautions · 01

Telemedicine Outcome Concerns

1,188 papers

19.8% of this theme group

Highlights uncertainties about effectiveness, patient satisfaction, and long‑term health outcomes of remote care.

Telemedicine (762) · Telehealth (476) · Telerehabilitation (118) · Health care (319)

The Role of Telemedicine in Improving Healthcare Outcome: A Review

Assessing the Efficiency and Patient Satisfaction of Telemedicine in Managing Chronic Health Conditions

View research history
YearShare index
202251.7
202348.4
202444.2
202563.5
eHealth Adoption BarriersCautions · 02

eHealth Adoption Barriers

1,185 papers

19.8% of this theme group

Identifies practical and quality‑assessment challenges when deploying digital health tools in low‑resource settings.

Health informatics (239) · Health administration (157) · Nursing research (113) · Medical device (92)

Challenges of using e-health technologies to support clinical care in rural Africa: a longitudinal mixed methods study exploring primary hea

Development and analysis of quality assessment tools for different types of patient information – websites, decision aids, question prompt l

View research history
YearShare index
202223.2
202321.1
202427.6
202544.8
Pharmacogenomics UncertaintyCautions · 03

Pharmacogenomics Uncertainty

921 papers

15.3% of this theme group

Discusses difficulties in biomarker validation, regulatory acceptance, and predictive modeling for drug development.

Drug discovery (202) · Drug (160) · Pharmacogenomics (109) · Pharmacogenetics (64)

Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape

Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologic

View research history
YearShare index
2022154.6
2023158.9
2024165.9
2025206.7
Digital Mental‑Health RisksCautions · 04

Digital Mental‑Health Risks

884 papers

14.7% of this theme group

Examines adoption patterns, efficacy gaps, and user‑experience issues in digital psychological interventions.

Digital health (480) · Psychological intervention (265) · Mental health (159) · Health care (262)

Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review

Digital Health Interventions for Promoting Healthy Aging: A Systematic Review of Adoption Patterns, Efficacy, and User Experience

View research history
YearShare index
2022790.2
2023807.5
2024810.9
20251159.7
COVID‑19 Telehealth AdoptionCautions · 05

COVID‑19 Telehealth Adoption

670 papers

11.2% of this theme group

Explores clinician perspectives and barriers to sustained telemedicine use during and after the pandemic.

Pandemic (431) · Coronavirus disease 2019 (360) · Telemedicine (348) · 2019-20 coronavirus outbreak (77)

Community Mental Health Clinicians’ Perspectives on Telehealth During the COVID-19 Pandemic: Mixed Methods Study

Exploring Ophthalmologists’ Adoption of Telemedicine during the COVID-19 Pandemic: A Mixed Methods Study

View research history
YearShare index
2022544.1
2023376.7
2024243.3
2025191.2
Precision Medicine ImplementationCautions · 06

Precision Medicine Implementation

621 papers

10.3% of this theme group

Addresses awareness gaps, adoption hurdles, and ethical considerations in personalized oncology care.

Precision medicine (249) · Personalized medicine (164) · Cancer (103) · Oncology (57)

Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Sur

Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review

View research history
YearShare index
2022767.8
20231043.6
2024798.0
2025771.4
AI in Clinical PracticeCautions · 07

AI in Clinical Practice

531 papers

8.8% of this theme group

Considers ethical, reliability, and integration challenges of artificial‑intelligence tools in health care.

Applications of artificial intelligence (102) · Transformative learning (77) · Health care (188) · Precision medicine (102)

Artificial intelligence in healthcare: revolutionizing precision medicine, predictive analytics, and ethical considerations in autonomous di

Artificial Intelligence in Medicine: Transforming Diagnosis, Treatment, and Healthcare Delivery

View research history
YearShare index
2022534.7
2023549.6
2024538.1
2025839.2

Opportunities

87,120 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Digital Health UsabilityOpportunities · 01

Digital Health Usability

1,079 papers

18.0% of this theme group

Presents models and design approaches to improve clinical usability of emerging digital health technologies.

Digital health (282) · Health care (348) · Health informatics (142) · Psychological intervention (156)

Development of an Evidence-Based Conceptual Model of the Health Care Sector Under Digital Transformation: Integrative Review

HCI-modelling for improving the clinical usability of digital health technologies

View research history
YearShare index
2022541.3
2023554.6
2024543.2
2025853.3
In‑Silico Drug ScreeningOpportunities · 02

In‑Silico Drug Screening

994 papers

16.6% of this theme group

Highlights computational docking and virtual screening methods for accelerating therapeutic discovery.

Drug discovery (282) · In silico (99) · Drug (156) · Docking (85)

Exploring Cimetidine\nas a Potential Therapeutic Attenuator\nagainst Amyloid Formation in Parkinson’s Disease: Spectroscopic\nand Microscopi

Design, Synthesis,\nand Biological Evaluation of 5‑Formyl-pyrrolo[3,2‑<i>b</i>]pyridine-3-carboxamides as New Selective, Potent,

View research history
YearShare index
2022167.5
2023172.4
2024180.4
2025218.9
Computational Chemistry for DrugsOpportunities · 03

Computational Chemistry for Drugs

826 papers

13.8% of this theme group

Shows how molecular docking and chemical‑space exploration support targeted drug design.

Drug discovery (535) · Computational biology (222) · Drug (223) · Chemical space (66)

Assessing molecular docking tools: understanding drug discovery and design

Molecular Docking in Computer-Aided Drug Discovery: A Powerful Tool for Targeted Therapeutics

View research history
YearShare index
2022281.3
2023298.1
2024330.7
2025367.6
Remote Physical TherapyOpportunities · 04

Remote Physical Therapy

824 papers

13.7% of this theme group

Explores telehealth applications for senior care, palliative communication, and rehabilitation services.

Telemedicine (475) · Telehealth (353) · Telerehabilitation (87) · Physical therapy (75)

Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study

Telehealth for the study of palliative care communication: opportunities, methodological challenges, and recommendations

View research history
YearShare index
202251.7
202348.4
202444.2
202563.5
Pharmacogenomics‑Driven PrecisionOpportunities · 05

Pharmacogenomics‑Driven Precision

763 papers

12.7% of this theme group

Advances personalized treatment plans through genomic profiling and deep‑learning analytics.

Precision medicine (283) · Personalized medicine (216) · Disease (142) · Pharmacogenomics (61)

Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease

Deep Learning for Precision Medicine: Advancing Personalized Treatment Plans in Oncology

View research history
YearShare index
20221255.2
20231115.6
20241012.0
20251296.9
Wearable IoT MonitoringOpportunities · 06

Wearable IoT Monitoring

762 papers

12.7% of this theme group

Describes wearable and IoT solutions for continuous patient monitoring in remote and underserved areas.

Wearable computer (117) · Medical device (84) · Remote patient monitoring (76) · Internet of Things (49)

Wearable technology. Health-care solutions for a growing global population.

IoT Based Effective Wearable Healthcare Monitoring System For Remote Areas

View research history
YearShare index
202240.5
202342.2
202444.3
202574.3
Biomarker‑Based Cancer PersonalizationOpportunities · 07

Biomarker‑Based Cancer Personalization

752 papers

12.5% of this theme group

Focuses on bioinformatics and circulating tumor cell analyses to tailor cancer therapies.

Cancer (241) · Precision medicine (207) · Breast cancer (90) · Lung cancer (44)

Bioinformatics-Based Analysis of Circulating Tumor Cells: A Methodological Overview of Personalized Cancer Treatment

[Molecular biomarkers in breast cancer : advances in precision medicine].

View research history
YearShare index
2022776.6
20231055.1
2024810.2
2025787.3

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Promising29.7%37.4%
Problem-identifying29.0%9.8%
Descriptive18.8%17.6%
Breakthrough12.7%26.0%
Cautionary6.4%4.4%
Comparative2.5%3.9%
Critical0.9%0.9%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceThe future of digital health with federated learning4,5732.66%2,251 (49.2%)2.66%
Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media2920.17%167 (57.2%)0.17%
Bias & fairnessChallenges and recommendations for wearable devices in digital health: Data quality, interoperability, health equity, fa990.06%45 (45.5%)0.06%
Hardware, e-waste & supply chainE-waste for health: recycling smartphones for health monitoring240.01%7 (29.2%)0.01%
Concentration of compute powerDemonopolizing Medical Knowledge160.01%7 (43.8%)0.01%
Labour & data workNew Work—New Interventions: Digital Occupational Health Interventions and the Co-Creation of a Human-Centered Future of 110.01%6 (54.5%)0.01%
Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT100.01%4 (40.0%)0.01%
Carbon & emissions of computeSustainable AI-Enabled UAV Healthcare Logistics: Environmental, Social, and Governance Implications from a PRISMA-ScR Re30.0%1 (33.3%)0.0%
Water use00.0%0 (%)0.0%

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

DEMAND, SUPPLY & PLACE

Where demand signals run ahead of mapped supply — London

Compare demand signals in London’s newsflow with the healthtech categories mapped to each signal.

Expand panel +
HOW TO READ THE GAP

Signal percentile − supply percentile = gap in percentile points. Positive gaps highlight questions to investigate. A high signal can reflect spending pressure or access friction, as well as potential demand.

The comparison is relative to the signal families on this page. A supply percentile of zero means the lowest relative reading, not zero companies. It is a prioritisation clue, not measured market size or unmet demand.

COMPARISON PERIOD2025-05-01 to 2026-05-01Against 2024-05-01 to 2025-05-01Explore the signals ↓

The opportunity, in one view

Signal and mapped-supply percentiles, their gap, and change in the signal’s article share.

Swipe horizontally to compare all columns →

7 London demand signals compared with mapped healthtech supply
Signal familySignal percentileSupply percentileRelative gapGap (points)Signal share vs prior year
Ageing & elder care ↗Disease Burden66.716.7+50.0+17.4%
Air pollution ↗Environmental Driver45.816.7+29.1-1.2%
Mental health ↗Disease Burden50.066.7-16.7—
Cancer burden ↗Disease Burden41.7100.0-58.3-27.1%
Diabetes, hypertension & cardiac burden ↗Disease Burden25.0—No matching category——
Maternal & child health ↗Disease Burden33.3—No matching category—+5.6%
Layoffs & income shocks ↗Spending Pressure87.5—No matching category—+10.1%

Showing all 7 signals. Select a family for its history and mapped categories.

Where the signals are loudest

All 12 city readings for these demand families in the comparison geography. London is highlighted.

Mentions per 10,000 articles

Each city’s reading is a share of its own coverage. Rows cover all of the United Kingdom for this page's signal families; London is marked.

Cambridge165.0

Cancer burden · Diabetes, hypertension & cardiac burden · Layoffs & income shocks

Inverness160.2

Ageing & elder care · Mental health · Maternal & child health

Bolton149.3

Maternal & child health · Mental health · Layoffs & income shocks

Blackburn148.0

Mental health · Cancer burden · Layoffs & income shocks

Norwich125.8

Maternal & child health · Cancer burden · Ageing & elder care

Sheffield113.6

Mental health · Maternal & child health · Air pollution

Cheshire108.4

Layoffs & income shocks · Cancer burden · Mental health

Oxford81.9

Cancer burden · Mental health · Layoffs & income shocks

LondonThis page81.8

Layoffs & income shocks · Cancer burden · Air pollution

Glasgow79.7

Maternal & child health · Layoffs & income shocks · Cancer burden

Brighton76.7

Cancer burden · Layoffs & income shocks · Maternal & child health

York67.7

Maternal & child health · Layoffs & income shocks · Cancer burden

Inside the leading signals

Open any signal for its quarterly history
DISEASE BURDENAgeing & elder care+50.0percentile-point gap
THE OPERATING HYPOTHESIS

An ageing base can shift demand toward geriatric, home and chronic care.

7.03mentions per 10,000 articles+17.4%share change vs prior year

Mapped healthtech categories

  • At Home Diagnostics108

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of London coverage

Mentions per 10,000 articles · zero baseline

04812162024Q3: 52024Q32024Q4: 62024Q42025Q1: 72025Q12025Q2: 42025Q22025Q3: 132025Q32025Q4: 32025Q42026Q1: 32026Q1
View quarterly signal counts
Ageing & elder care in London coverage
QuarterMentionsPer 10,000 articles
2024Q3145.45
2024Q4166.82
2025Q1197.16
2025Q2114.57
2025Q34213.81
2025Q493.73
2026Q1123.86

Where this signal concentrates in the comparison geography

Inverness84.3 / 10,000
ENVIRONMENTAL DRIVERAir pollution+29.1percentile-point gap
THE OPERATING HYPOTHESIS

Sustained air-quality stress can pull respiratory and cardiac care demand with it.

10.06mentions per 10,000 articles-1.2%share change vs prior year

Mapped healthtech categories

  • At Home Diagnostics108

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of London coverage

Mentions per 10,000 articles · zero baseline

051015202024Q3: 52024Q32024Q4: 102024Q42025Q1: 122025Q12025Q2: 122025Q22025Q3: 172025Q32025Q4: 82025Q42026Q1: 52026Q1
View quarterly signal counts
Air pollution in London coverage
QuarterMentionsPer 10,000 articles
2024Q3155.84
2024Q42410.23
2025Q13212.07
2025Q22912.05
2025Q35417.75
2025Q4208.29
2026Q1175.46

Where this signal concentrates in the comparison geography

London10.4 / 10,000
DISEASE BURDENMental health-16.7percentile-point gap
THE OPERATING HYPOTHESIS

Mental-health pressure can pull counselling and tele-psychiatry demand where it surfaces.

8.82mentions per 10,000 articles

Mapped healthtech categories

  • Loneliness Economy152
  • Mental Healthtech122

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of London coverage

Mentions per 10,000 articles · zero baseline

04913172024Q3: 22024Q32024Q4: 52024Q42025Q1: 32025Q12025Q2: 32025Q22025Q3: 152025Q32025Q4: 32025Q42026Q1: 102026Q1
View quarterly signal counts
Mental health in London coverage
QuarterMentionsPer 10,000 articles
2024Q372.73
2024Q4125.12
2025Q193.39
2025Q293.74
2025Q34615.12
2025Q493.73
2026Q13410.93

Where this signal concentrates in the comparison geography

Sheffield40.1 / 10,000
DISEASE BURDENCancer burden-58.3percentile-point gap
THE OPERATING HYPOTHESIS

Cancer burden can pull screening, diagnostics and oncology capacity demand.

15.58mentions per 10,000 articles-27.1%share change vs prior year

Mapped healthtech categories

  • Life Sciences253
  • At Home Diagnostics108

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of London coverage

Mentions per 10,000 articles · zero baseline

091827362024Q3: 132024Q32024Q4: 142024Q42025Q1: 312025Q12025Q2: 242025Q22025Q3: 82025Q32025Q4: 212025Q42026Q1: 132026Q1
View quarterly signal counts
Cancer burden in London coverage
QuarterMentionsPer 10,000 articles
2024Q33413.24
2024Q43314.07
2025Q18331.3
2025Q26024.93
2025Q3268.55
2025Q45321.98
2026Q14213.5

Where this signal concentrates in the comparison geography

Cambridge85.6 / 10,000
Oxford28.2 / 10,000
DISEASE BURDENDiabetes, hypertension & cardiac burden—supply not mapped
THE OPERATING HYPOTHESIS

Chronic cardiometabolic burden can turn into decades of management demand per patient.

5.97mentions per 10,000 articles

Mapped healthtech categories

This signal has no matching category in the page’s healthtech market map, so no supply percentile or gap is assigned.

Quarterly share of London coverage

Mentions per 10,000 articles · zero baseline

024792024Q3: 72024Q32024Q4: 22024Q42025Q1: 32025Q12025Q2: 62025Q22025Q3: 52025Q32025Q4: 72025Q42026Q1: 32026Q1
View quarterly signal counts
Diabetes, hypertension & cardiac burden in London coverage
QuarterMentionsPer 10,000 articles
2024Q3207.79
2024Q462.56
2025Q193.39
2025Q2156.23
2025Q3175.59
2025Q4177.05
2026Q1123.86

Where this signal concentrates in the comparison geography

DISEASE BURDENMaternal & child health—supply not mapped
THE OPERATING HYPOTHESIS

Maternal and child burden can pull immunisation, nutrition and pediatric care demand.

6.86mentions per 10,000 articles+5.6%share change vs prior year

Mapped healthtech categories

This signal has no matching category in the page’s healthtech market map, so no supply percentile or gap is assigned.

Quarterly share of London coverage

Mentions per 10,000 articles · zero baseline

0358112024Q3: 82024Q32024Q4: 52024Q42025Q1: 72025Q12025Q2: 22025Q22025Q3: 92025Q32025Q4: 42025Q42026Q1: 92026Q1
View quarterly signal counts
Maternal & child health in London coverage
QuarterMentionsPer 10,000 articles
2024Q3228.57
2024Q4145.97
2025Q1197.16
2025Q272.91
2025Q3289.2
2025Q4124.98
2026Q1289.0

Where this signal concentrates in the comparison geography

SPENDING PRESSURELayoffs & income shocks—supply not mapped
THE OPERATING HYPOTHESIS

Layoff cycles can pull discretionary spend back toward value offerings.

26.27mentions per 10,000 articles+10.1%share change vs prior year

Mapped healthtech categories

This signal has no matching category in the page’s healthtech market map, so no supply percentile or gap is assigned.

Quarterly share of London coverage

Mentions per 10,000 articles · zero baseline

0102030402024Q3: 212024Q32024Q4: 262024Q42025Q1: 312025Q12025Q2: 202025Q22025Q3: 272025Q32025Q4: 172025Q42026Q1: 352026Q1
View quarterly signal counts
Layoffs & income shocks in London coverage
QuarterMentionsPer 10,000 articles
2024Q35421.03
2024Q46126.01
2025Q18431.68
2025Q25020.77
2025Q38427.61
2025Q44317.83
2026Q110935.03

Where this signal concentrates in the comparison geography

London27.2 / 10,000
RESEARCH & CHANGING CONVERSATIONS

Related research and changing coverage

London healthtech coverage

Expand panel +
RESEARCH CONTEXT · 2022

Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series

BMJ

610 citations in the snapshot

RESEARCH CONTEXT · 2021

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

The Lancet Infectious Diseases

455 citations in the snapshot

RESEARCH CONTEXT · 2020

Investigating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Surface and Air Contamination in an Acute Healthcare Setting During the Peak of the Coronavirus Disease 2019 (COVID-19) Pandemic in London

Clinical Infectious Diseases

252 citations in the snapshot

RESEARCH CONTEXT · 2020

Nosocomial Transmission of Coronavirus Disease 2019: A Retrospective Study of 66 Hospital-acquired Cases in a London Teaching Hospital

Clinical Infectious Diseases

241 citations in the snapshot

What is growing in this coverage

London coverage of this page's demand families

KeywordRecent articlesPrior articlesShare change
daycare vaccination rules408345.9%
vaccine requirements for minors378312.5%
childhood immunization laws4010256.7%
pediatric catch-up vaccinations4011224.3%
pollution monitoring221530.8%
air quality standards261922.0%

Share changes describe coverage in the stated comparison periods, not search demand or market size.

UNDERSTAND THE LANDSCAPE

Healthtech in London: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

KEEP EXPLORING

Put London in context

All landscapes ↗

Company ecosystem snapshot: 31 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon